Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 Next >
Harvard University and SiOnyx Partner to Commercialize Black Silicon
October 13, 2008
Harvard Spinout Obtains Exclusive Rights to University's Portfolio of Black Silicon Patents, Aims to Revolutionize Photonics Read More
from Business Wire News Releases
Sirtris Pharmaceuticals Presents at the American Diabetes Association's 68th Annual Scientific Sessions June 8
June 04, 2008
from Business Wire News Releases
Mergent, Inc. Announces Changes to the HealthShares(TM) Metabolic-Endocrine Disorders Index
June 02, 2008
from PR Newswire
GlaxoSmithKline Successfully Completes Tender Offer for Shares of Sirtris Pharmaceuticals
June 02, 2008
from PR Newswire
GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
May 02, 2008
from PR Newswire
Sirtris Pharmaceuticals Reports First Quarter 2008 Financial Results
May 01, 2008
from Business Wire News Releases
Genstruct and Sirtris Pharmaceuticals Win Bio-IT World's Best Practices Award
April 30, 2008
Causal Network Modeling Provides Powerful Approach to Modeling Complex Biological Systems for Type 2 Diabetes Read More
from PR Newswire
BellwetherReport.com Initiates Analyst Coverage on BRCM, ANAD, SIRT and REST
April 23, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development
April 22, 2008
from PR Newswire
Sirtris Announces SRT501 Lowers Glucose in Twice-Daily Dosing Clinical Trial; Study Suggests Dose Response for Proprietary Formulation of Resveratrol in Type 2 Diabetics
April 17, 2008
Clinical Trial Further Demonstrates Efficacy of SIRT1 Activation In Humans Read More
from Business Wire News Releases
Sirtris Scientific Advisory Board Co-Chairs Publish First In-Vivo Data Showing SIRT1 Enzyme Can Suppress Tumor Development
April 16, 2008
from Business Wire News Releases
ADDING MULTIMEDIA Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome
April 02, 2008
from Business Wire News Releases
Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELAS Syndrome
April 02, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Presents at American Chemical Society April 7
April 01, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Scientific Advisor Shows SIRT1 Activation Improves Huntington's Disease In Preclinical Model
March 28, 2008
Presentations Will Take Place at the Pasteur Institute, March 28 and the British Societies for Cell and Developmental Biology at the University of Warwick, March 31 Read More
from Business Wire News Releases
Sirtris Pharmaceuticals Announces the Appointment of Paul A. Friedman, M.D., President and CEO of Incyte Corporation, to its Board of Directors
March 25, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Presents at Future Leaders in the Biotechnology Industry Conference March 27
March 24, 2008
from Business Wire News Releases
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
March 20, 2008
from PR Newswire
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
March 19, 2008
from PR Newswire
Sirtris Announces First U.S. Patent Issued On Class of SIRT1 Activators; Patent Covers First NCE to Enter Human Clinical Trials
March 19, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Presents at Cowen and Company Health Care Conference & the IBC Life Sciences Metabolic Disorders Conference on March 18
March 13, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Sublicenses Portion of Lifespan Technology in Plants to Bayer CropScience AG
March 12, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals In-Licenses Key Genetic Driver of Cellular Stress Resistance and Longevity in Mammals from Robarts Research Institute
March 11, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Collaborator Presents Neuroprotective Data for Oral Drug Candidate SRT501 at North American Neuro-Ophthalmology Society Meeting
March 10, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis
March 04, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Reports Fourth Quarter and 2007 Financial Results; Significant Progress Achieved
February 25, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Enters Collaborative Study Testing New Chemical Entities and Clinical Drug Candidate In Multiple Models of Cancer with the National Cancer Institute
February 21, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals Co-Founder Presents First In-Vivo, Preclinical Data Showing SIRT1 Activation Can Suppress Tumor Formation and Growth
February 20, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals to Webcast Conference Call for Fiscal 2007 Financial Results
February 12, 2008
from Business Wire News Releases
Sirtris Pharmaceuticals to Present at the BIO CEO & Investor Conference February 12
February 07, 2008
from Business Wire News Releases
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here